UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
976
DELISTED
Exact Sciences
EXAS
| $4.74M | 0.01% |
405,297
-27,100
| -6% | -$311K |
|
977
Angi Inc
ANGI
$194M
| $4.71M | 0.01% |
31,120
+24,885
| +399% | +$3.56M |
|
|
INFI
978
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $4.64M | 0.01% |
336,219
+8,600
| +3% | +$121K |
|
979
Hope Bancorp
HOPE
$1.82B
| $4.58M | 0.01% |
276,080
-206,527
| -43% | -$3.19M |
|
|
SVU
980
DELISTED
SUPERVALU Inc.
SVU
| $4.58M | 0.01% |
89,755
+2,300
| +3% | +$113K |
|
981
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $4.57M | 0.01% |
33,693
-5,587
| -14% | -$724K |
|
982
Banco de Chile
BCH
$21B
| $4.56M | 0.01% |
174,857
+17,509
| +11% | +$463K |
|
|
RVBD
983
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $4.56M | 0.01% |
252,201
-95,000
| -27% | -$1.54M |
|
984
H.B. Fuller
FUL
$3.2B
| $4.55M | 0.01% |
87,433
-1,031
| -1% | -$50.2K |
|
985
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $4.51M | 0.01% |
107,926
+29,499
| +38% | +$1.19M |
|
|
CYN
986
DELISTED
CITY NATIONAL CORPORATION
CYN
| $4.48M | 0.01% |
56,542
-7,404
| -12% | -$546K |
|
|
ITC
987
DELISTED
ITC HOLDINGS CORP
ITC
| $4.47M | 0.01% |
140,100
-5,700
| -4% | -$182K |
|
988
Aegon
AEG
$14B
| $4.46M | 0.01% |
+692,708
| New | +$3.94M |
|
989
Arthur J. Gallagher & Co
AJG
$64.3B
| $4.42M | 0.01% |
94,262
-600
| -0.6% | -$27.9K |
|
990
W.P. Carey
WPC
$16.4B
| $4.41M | 0.01% |
73,329
+3,165
| +5% | +$199K |
|
|
HME
991
DELISTED
HOME PROPERTIES, INC
HME
| $4.39M | 0.01% |
81,842
+2,600
| +3% | +$146K |
|
|
RAD
992
DELISTED
Rite Aid Corporation
RAD
| $4.38M | 0.01% |
43,266
-6,615
| -13% | -$704K |
|
993
Packaging Corp of America
PKG
$22.8B
| $4.32M | ﹤0.01% |
68,275
+3,200
| +5% | +$194K |
|
994
United Therapeutics
UTHR
$22B
| $4.28M | ﹤0.01% |
37,818
+1,650
| +5% | +$149K |
|
995
3D Systems Corp
DDD
$593M
| $4.26M | ﹤0.01% |
45,866
-81
| -0.2% | -$5.68K |
|
|
MACK
996
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $4.22M | ﹤0.01% |
100,472
+750
| +0.8% | +$21.7K |
|
997
Guidewire Software
GWRE
$13.3B
| $4.2M | ﹤0.01% |
85,652
-5,903
| -6% | -$278K |
|
998
NCR Voyix
VYX
$1.31B
| $4.2M | ﹤0.01% |
200,748
+6,698
| +3% | +$149K |
|
999
iShares Core S&P 500 ETF
IVV
$898B
| $4.16M | ﹤0.01% |
+22,400
| New | +$3.99M |
|
1000
Columbia Banking Systems
COLB
$8.87B
| $4.14M | ﹤0.01% |
150,524
-7,988
| -5% | -$209K |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.